The government is currently prohibited by law from negotiating drug prices for Medicare. Medicare Part D is a federal government program which subsidizes the costs of prescriptions drugs for people enrolled in Medicare. Since it was approved by Congress in 2003 39 million Americans have enrolled in the program which now costs more than $80 billion per year. Opponents of Medicare Part D argue that it should be changed to allow the federal government to negotiate prices with pharmaceutical companies. They point out that the Veterans Affairs administration is allowed to negotiate prices and…
Read more76% 是的 |
24% 不 |
76% 是的 |
18% 不 |
6% 不,政府不应该干涉自由市场 |
See how support for each position on “Medicare Drug Prices” has changed over time for 121k America voters.
正在载入数据......
Loading chart...
See how importance of “Medicare Drug Prices” has changed over time for 121k America voters.
正在载入数据......
Loading chart...